Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	58.44	69.19	48.16	-25	71.52	26.75
Depreciation & Amortization	226.19	169.16	149.26	134.15	68.92	61.55
Other Amortization	5.49	6.02	8.64	8.29	3.41	8.97
Asset Writedown & Restructuring Costs	-	-	-	4.79	-	-
Loss (Gain) From Sale of Investments	-1.19	-2.03	-1.24	-	-	-
Stock-Based Compensation	39.75	32.4	27.14	22.87	24.26	21.91
Other Operating Activities	-24.5	-14.78	21.07	-8.15	-78.02	0.06
Change in Accounts Receivable	-5.31	-4.41	3.59	-21.78	-22.52	-10.37
Change in Inventory	-0.02	13.93	14.17	48.27	-2.3	-8.27
Change in Accounts Payable	4.48	-11.28	5.06	-0.71	-5.83	3.77
Change in Unearned Revenue	-0.06	-	-	-	-	-
Change in Other Net Operating Assets	-12.36	-53.21	-1.09	-38.5	44.13	-10.43
Operating Cash Flow	290.92	204.98	274.75	124.23	103.56	93.94
Operating Cash Flow Growth	50.21%	-25.39%	121.16%	19.96%	10.23%	238.13%
Capital Expenditures	-1.62	-1.65	-0.46	-1.62	-1.94	-5.55
Cash Acquisitions	-	-267.54	-	-572.07	-	-
Sale (Purchase) of Intangibles	-	-	-	-	-	-368.23
Investment in Securities	-53.6	-18.57	-70.35	-	-	-
Investing Cash Flow	-55.23	-287.76	-70.81	-573.69	-1.94	-373.77
Long-Term Debt Issued	-	325	241.5	517.68	-	338.32
Total Debt Issued	11.83	325	241.5	517.68	-	338.32
Long-Term Debt Repaid	-	-305.66	-301.14	-75	-50	-49
Net Debt Issued (Repaid)	-52.76	19.34	-59.64	442.68	-50	289.32
Issuance of Common Stock	4.83	11.07	9.1	12.15	12.71	7.34
Repurchase of Common Stock	-62.39	-79.2	-83.36	-18.11	-52.01	-2.26
Other Financing Activities	-19.38	-11.83	-6.28	-	-	-7.93
Financing Cash Flow	-129.7	-60.6	-140.18	436.72	-89.3	286.47
Net Cash Flow	105.99	-143.38	63.76	-12.74	12.31	6.64
Free Cash Flow	289.3	203.33	274.29	122.61	101.61	88.4
Free Cash Flow Growth	50.34%	-25.87%	123.71%	20.66%	14.95%	314.13%
Free Cash Flow Margin	38.21%	32.20%	48.39%	26.43%	36.70%	28.51%
Free Cash Flow Per Share	7.29	5.03	6.56	3.62	2.48	2.52
Cash Interest Paid	72.29	62.43	73.26	52.53	17.61	18.97
Cash Income Tax Paid	48.38	52.09	24.21	10.4	3.01	0.48
Levered Free Cash Flow	314.88	362.08	274.32	70.53	109.21	-288.37
Unlevered Free Cash Flow	362.93	402.3	317.77	101.75	118.93	-279.29
Change in Working Capital	-13.26	-54.98	21.73	-12.71	13.49	-25.3

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q